NY-ESO-1 Based Immunotherapy of Cancer: Current Perspectives

NY-ESO-1 Based Immunotherapy of Cancer: Current Perspectives

<p dir="ltr">NY-ESO-1 or New York esophageal squamous cell carcinoma 1 is a well-known cancer-testis antigen (CTAs) with re-expression in numerous cancer types. Its ability to elicit spontaneous humoral and cellular immune responses, together with its restricted expression pattern, h...

Full description

Saved in:
Bibliographic Details
Main Author: Remy Thomas (702843) (author)
Other Authors: Ghaneya Al-Khadairi (14153274) (author), Jessica Roelands (7516439) (author), Wouter Hendrickx (44559) (author), Said Dermime (79420) (author), Davide Bedognetti (2632474) (author), Julie Decock (44558) (author)
Published: 2018
Subjects:
Biomedical and clinical sciences
Immunology
Oncology and carcinogenesis
cancer-testis antigen
NY-ESO-1
adoptive T cell therapy
vaccine
immune checkpoint
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items